Fo Shou San, an Ancient Chinese Herbal Decoction, Protects Endothelial Function through Increasing Endothelial Nitric Oxide Synthase Activity

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Bi, Cathy W C ^a   Xu, Li ^a   Tian, Xiao Yu ^b   Liu, Jian ^b   Zheng, Ken Y Z ^a   Lau, Chi Wai ^b   Lau, David T W ^a   Choi, Roy C Y ^a   Dong, Tina T X ^a   Huang, Yu ^b   Tsim, Karl W K ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANTIOXIDANT; CALCIUM ION; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FO SHOU SAN; HOMOCYSTEINE; PLANT MEDICINAL PRODUCT; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; TRICIRIBINE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGELICA SINENSIS; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MALE; NONHUMAN; OXIDATIVE STRESS; PHYTOCHEMISTRY; PLANT ROOT; RAT; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR RING; VASODILATATION;

EID: 84871356507     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051670     Document Type: Article

References (41)

1. Bi CW, Xu L, Zhang WL, Zhan JY, Fu Q, et al. (2012) Fo Shou San, an ancient herbal decoction prepared from Angelicae Sinensis Radix and Chuanxiong Rhizoma induces erythropoietin expression: a signaling mediated by the reduced degradation of hypoxia-inducible factor in cultured liver cells. Planta Med. 78: 122-127.
2. Bi CW, Xie HQ, Xu L, Li J, Cheung AW, et al. (2010) Fo Shou San, an ancient herbal decoction prepared from Rhizoma Chuanxiong and Radix Angelica Sinensis, stimulates the production of hemoglobin and erythropoietin in cultured cells. Planta Med. 14: 1525-1530.
3. Ignarro LJ, (2002) Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. J Physiol Pharmacol. 53: 503-514.
4. Vanhaesebroeck B, Leevers SJ, Panayotou G, Waterfield MD, (1997) Phosphoinositide-3 kinase: a conserved family of signaling transducers. TIBS. 22: 267-272.
5. Lee JH, Yang ES, Park JW, (2003) Inactivation of NADP+-dependent isocitrate dehydrogenase by peroxynitrite. Implications for cytotoxicity and alcohol-induced liver injury. J Biol Chem. 278: 51360-51371.
6. Mikkelsen RB, Wardman P, (2003) Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene 22: 5734-5754.
7. Crane BR, Arvai AS, Ghosh DK, Wu C, Getzoff ED, et al. (1998) Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science. 279: 2121-2126.
8. Alderton WK, Cooper CE, Knowles RG, (2001) Nitric oxide synthases: structure, function and inhibition. Biochem J. 357: 593-615.
9. Kietadisorn R, Juni RP, Moens AL, (2012) Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities. Am J Physiol Endocrinol Metab. 302: E481-E495.
10. Hink U, Li H, Mollnau H, Oelze M, Matheis E, et al. (2001) Forstermann U, Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res. 88: e14-22.
11. Higashi Y, Sasaki S, Nakagawa K, Fukuda Y, Matsuura H, et al. (2002) Tetrahydrobiopterin enhances forearm vascular response to acetylcholine in both normotensive and hypertensive individuals [ast]. Am J Hypertens. 15: 326-332.
12. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, et al. (2002) Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res. 90: e58-65.
13. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, et al. (2003) Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest. 111: 1201-1209.
14. Takimoto E, Champion HC, Li M, Ren S, Rodriguez ER, et al. (2005) Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. J Clin Invest. 115: 1221-1231.
15. Moens AL, Champion HC, Claeys MJ, Tavazzi B, Kaminski PM, et al. (2008) High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury. Circulation. 117: 1810-1819.
16. Michel T, Vanhoutte PM, (2010) Cellular signaling and NO production. Pflugers Arch. 459: 807-816.
17. Wong WT, Wong SL, Tian XY, Huang Y, (2010) Endothelial dysfunction: the common consequence in diabetes and hypertension. Journal of Cardiovascular Pharmacology. 55: 300-307.
18. Stanger O, Weger M, (2003) Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium. Clin Chem Lab Med. 41: 1444-1454.
19. Chan WK, Yao XQ, Ko WH, Huang Y, (2000) Nitric oxide mediated endothelium-dependent relaxation induced by glibenclamide in rat isolated aorta. Cardiovascular Research 46: 180-187.
20. Ohashi R, Yan SY, Mu H, Chai H, Yao QZ, et al. (2006) Effects of homocysteine and ginsenoside Rb1 on endothelial proliferation and superoxide anion production. Journal of surgical research 133: 89-94.
21. Lan TH, Xu ZW, Wang Z, Wu YL, Wu WK, et al. (2011) Ginsenoside Rb1 prevents homocysteine-induced endothelial dysfunction via PI3K/Akt activation and PKC inhibition. Biochemical Pharmacology 82: 148-155.
22. Hasin T, Elhanani O, Abassi Z, Tsonwin H, Aronheim A, (2011) Angiotensin II signaling up-regulates the immediate early transcription factor ATF3 in the left but not the right atrium. Basic Res Cardiol 106: 175-187.
23. Berndt N, Yang H, Trinczek B, Betzi S, Zhang Z, et al. (2010) The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane. Cell Death Differ. 17: 1795-1804.
24. Cai H, Liu D, Garcia JGN, (2008) CaM Kinase II-dependent pathophysiological signaling in endothelial cells. Cardiovascular Research 77: 30-34.
25. Stuhlinger MC, Tsao PS, Her JH, Kimoto M, Balint RF, et al. (2001) Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation 104: 2569-2572.
26. Shao ML (2010) Pharmacopoeia of the People's Republic of China (Part I). Beijing: Chemical Industry Press, China; 144.
27. Suzuki A, Yamamoto M, Jokura H, Fujii A, Tokimitsu I, et al. (2007) Ferulic acid restores endothelium-dependent vasodilation in aortas of spontaneously hypertensive rats. Am J Hypertens. 20: 508-513.
28. Wang B, Quyang J, Liu Y, (2004) General ferulate inhibits atherosclerogenesis in hyperlipidemia rabbits. J Cardiovasc Pharmacol. 43: 549-554.
29. Ma ZC, Hong Q, Wang YG, Tan HL, Xiao CR, et al. (2010) Ferulic acid protects human umbilical vein endothelial cells from radiation-induced oxidative stress by phosphatidylinositol 3-kinase and extracellular signal-regulated kinase pathways. Biol Pharm Bull 33: 29-34.
30. Suzuki A, Kagawa D, Fujii A, (2002) Short- and long- term effects of ferulic acid on blood pressure in spontaneously hypertensive rats. Am J Hypertens. 15: 351-367.
31. Chen ZY, Zhang ZS, Ho WKK, Zhu M, Kwan KY, et al. (1998) Endothelium-dependent relaxation induced by hawthorn extract in the rat isolated mesenteric artery. Life Sciences 63: 1983-1991.
32. Leung KW, Leung FP, Huang Y, Mak NK, Wong RNS, (2007) Non-genomic effects of ginsenoside-Re in endothelial cells via glucocorticoid receptor. FEBS Letters 581: 2423-2428.
33. Wong WT, Tian XY, Xu A, Jun Y, Lau CW, et al. (2011) Adiponectin is required for PPARγ-mediated improvement of endothelial function in diabetic mice. Cell Metabolism 14: 104-115.
34. Tang EHC, Leung FP, Huang Y, Feletou M, So KF, et al. (2007) Calcium and reactive oxygen species increase in endothelial cells in response to releasers of endothelium-derived contracting factor. British Journal of Pharmacology. 151: 15-23.
35. Huang Y, Chan NWK, Lau CW, Yao XQ, Chan FL, et al. (1999) Involvement of endothelium/nitric oxide in vasorelaxation induced by purified green tea (-) epicatechin. Biochimica et Biophysica Acta. 1427: 322-328.
36. Leber A, Hemmens B, Klösch B, Goessler W, Raber G, et al. (1999) Characterization of recombinant human endothelial nitric-oxide synthase purified from the yeast Pichia pastoris. J. Biol.Chem. 274: 37658-37664.
37. Hemmens B, Goessler W, Schmidt K, Mayer B, (2000) Role of bound zinc in dimer stabilization but not enzyme activity of neuronal nitric oxide synthase. J. Biol. Chem. 275: 35786-35791.
38. Zou M-H, Shi C, Cohen RA, (2002) Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. The Journal of Clinical Investigation. 109: 817-826.
39. Li JM, Shah AM, (2001) Differential NADPH- versus NADH-dependent superoxide production by phagocyte-type endothelial cell NADPH oxidase. Cardiovascular Research. 52: 477-486.
40. Li Y, Zhu H, Kuppusamy P, Roubaud V, Zewier JL, et al. (1998) Validation of lucigenin (Bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems. J Biol Chem. 273: 2015-2023.
41. Hu Q, Zheng G, Zweier JL, Deshpande S, Irani K, et al. (2000) NADPH oxidase activation increases the sensitivity of intracellular Ca2+ stores to inositol 1, 4, 5-trisphosphate in human endothelial cells. J Biol Chem. 275: 15749-15757.